CVRx Inc (CVRX) Stock Analysis

CVRx Inc (CVRX) is a publicly traded company in the HEALTHCARE sector. It trades at $5.43, carries a market capitalization of $148.07M. This page summarizes the public market data, fundamentals, and frequently asked questions for CVRX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $5.43
• Market Cap: $148.07M
• EPS: $-2.01
• 52-Week High: $11.30
• 52-Week Low: $4.37

Market Sentiment

CVRx Inc currently has a Bullish sentiment score of 0.28.

About CVRx Inc

CVRx Inc. is a leading medical technology firm focused on innovative implantable devices that tackle chronic health issues, particularly hypertension and heart failure. Its flagship product, the Barostim Neo, utilizes advanced neuromodulation techniques to manage blood pressure effectively in patients who do not respond to traditional therapies. Committed to enhancing patient outcomes and addressing critical clinical needs, CVRx is strategically positioned to impact the cardiovascular sector ...

GNG Research Analysis

GNG Research scores CVRx Inc (CVRX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CVRX.

Frequently Asked Questions

Does CVRX pay dividends?

CVRx Inc (CVRX) does not currently pay a regular dividend.

What is CVRX's market cap?

CVRx Inc (CVRX) has a market capitalization of $148.07M with a current stock price of $5.43.